North America Colorectal Cancer Screening Market Share

Statistics for the 2023 & 2024 North America Colorectal Cancer Screening market share, created by Mordor Intelligence™ Industry Reports. North America Colorectal Cancer Screening share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of North America Colorectal Cancer Screening Industry

The North American colorectal cancer screening market is fragmented due to the presence of many small and large market players. These market players are involved in various strategic activities such as agreements, partnerships, and developments to increase the product portfolio of the companies in the region. Some key North American colorectal cancer screening market players are Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, F. Hoffmann-La Roche AG, Novigenix SA, Siemens Healthineers, and Sysmex Corporation.

North America Colorectal Cancer Screening Market Leaders

  1. Abbott Laboratories

  2. Epigenomics Inc.

  3. Exact Sciences Corporation

  4. Clinical Genomics Technologies Pty Ltd.

  5. Hemosure Inc.

*Disclaimer: Major Players sorted in no particular order

North America Colorectal Cancer Screening Market Concentration

North America Colorectal Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)